✦ LIBER ✦

Pharmacokinetics of lisinopril (MK521) in healthy young and elderly subjects and in elderly patients with cardiac failure

✍ Scribed by Gautam, P. C.; Vargas, E.; Lye, M.

Book ID: 127089817
Publisher: Pharmaceutical Press
Year: 1987
Tongue: English
Weight: 235 KB
Volume: 39
Category: Article
ISSN: 2042-7158
DOI: 10.1111/j.2042-7158.1987.tb03130.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Fluvoxamine pharmacokinetics in healthy

Fluvoxamine pharmacokinetics in healthy elderly subjects and elderly patients with chronic heart failure

✍ Rocco Orlando; Sara De Martin; Laura Andrighetto; Maura Floreani; Pietro Palatin 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 625 KB

Pharmacokinetics of ofloxacin in elderly

Pharmacokinetics of ofloxacin in elderly patients and in healthy young subjects

✍ M. Molinaro; P. Villani; M. B. Regazzi; R. Rondanelli; G. Doveri 📂 Article 📅 1992 🏛 Springer 🌐 English ⚖ 342 KB

Sibutramine pharmacokinetics in young an

Sibutramine pharmacokinetics in young and elderly healthy subjects

✍ I. D. Hind; J. E. Mangham; S. P. Ghani; R. E. Haddock; C. J. Garratt; R. W. Jone 📂 Article 📅 1999 🏛 Springer 🌐 English ⚖ 83 KB

Repaglinide pharmacokinetics in healthy

Repaglinide pharmacokinetics in healthy young adult and elderly subjects

✍ Vibeke Hatorp; Won-Chin Huang; Poul Strange 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 573 KB

Pharmacokinetics of the anti-inflammator

Pharmacokinetics of the anti-inflammatory drug ximoprofen in healthy young and elderly subjects: comparison with elderly rheumatic patients.

✍ IW Taylor; LF Chasseaud; T Taylor; I James; G Dorf; A Darragh 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 769 KB

Pharmacokinetics and bioavailability of

Pharmacokinetics and bioavailability of montelukast sodium (MK-0476) in healthy young and elderly volunteers

✍ Jamie J. Zhao; J. Douglas Rogers; Sherry D. Holland; Patrick Larson; Raju D. Ami 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 140 KB 👁 1 views

A study was conducted to (i) characterize the multiple-dose pharmacokinetics of oral montelukast sodium (MK-0476), 10 mg d 71 in healthy young subjects (N 12), (ii) evaluate the pharmacokinetics of montelukast in healthy elderly subjects (N 12), and (iii) compare the pharmacokinetics and oral bioava